(In the back row from the left) Research Professor Ho-yeon Lee of the Department of Chemistry, master's student Kyuhan Lee, doctoral students Junhyuk Park and Yeo-jin Park, (in the front row from the left) integrated master's and doctoral student Hyungbin Park (first author), Professor Mingon Kim (corresponding author), master's student Jiyoung Yoon. Provided by GIST

(In the back row from the left) Research Professor Ho-yeon Lee of the Department of Chemistry, master's student Kyuhan Lee, doctoral students Junhyuk Park and Yeo-jin Park, (in the front row from the left) integrated master's and doctoral student Hyungbin Park (first author), Professor Mingon Kim (corresponding author), master's student Jiyoung Yoon. Provided by GIST

View original image

Gwangju Institute of Science and Technology (GIST) announced on March 30 that Professor Mingon Kim's research team from the Department of Chemistry has presented a next-generation gene diagnostic technology that enables flexible design and detection of target genes for various diseases.


This technology allows for the design of customized diagnostic methods for "target genes" that require diagnosis, making it applicable to a wide range of diseases such as infectious diseases, cancers, and genetic disorders.


Gene-based diagnostic technologies, which diagnose diseases using genetic information (DNA or RNA) found in the body or in viruses, are widely used for diagnosing various conditions. The current standard method, the polymerase chain reaction (PCR) gene amplification test, offers high accuracy and sensitivity, but it has limitations due to its lengthy processing time and the need for specialized equipment and personnel.


To address these limitations, a "one-pot CRISPR" diagnostic method has been gaining attention. This method combines "gene scissors (CRISPR)"—which target specific disease-related genes—and "isothermal amplification," a technique that rapidly and massively replicates genes at a constant temperature.


However, these technologies face challenges because the speed of the reactions that detect genes and generate signals varies and is difficult to control. As a result, it is hard to find optimal conditions for each gene, and the flexibility in design is limited.

Next-generation personalized diagnostic platform based on gene editing (CRISPR). Provided by GIST

Next-generation personalized diagnostic platform based on gene editing (CRISPR). Provided by GIST

View original image

To overcome these limitations, the research team proposed a new approach that allows for the universal detection of "target genes" to diagnose diseases by controlling the gene scissors technology. In the gene scissors technique, a guide RNA, which acts like a navigation system in a car, locates the target gene, and then the engine—the Cas protein, which cuts the gene—acts at that site to produce a signal.


The research team introduced short "gene fragments (oligos)" that function as a brake to control the speed of the cutting and signal-generating processes independently.


In experiments using gene models with oligos of varying lengths, the team confirmed that the reaction speed could be precisely controlled depending on the oligo length, much like adjusting the strength of a brake. Based on these findings, they proposed a rule for designing optimal conditions. Moreover, when applied to 120 clinical samples collected from actual patients, the technology was able to determine infection status within about 20 minutes and demonstrated accuracy and sensitivity comparable to quantitative PCR (gene amplification tests). This confirms that the method enables faster and highly reliable diagnoses compared to existing methods, as well as its potential for clinical application.


This technology is not limited to specific diseases and can be universally applied to various gene targets. By adjusting the design of the oligos, it can be applied to a variety of fields, from diagnosing infectious diseases such as COVID-19 to cancers, allowing multiple diseases to be diagnosed on a single platform. Additionally, unlike conventional methods which require repetitive optimization for each gene, this technology simplifies the design process for disease diagnosis and greatly improves development efficiency.


Professor Mingon Kim stated, "This study is significant because it demonstrates the potential of a diagnostic platform that can be designed for various gene targets, rather than just for a single disease. While we have focused on validating performance with samples from patients with infectious diseases, we expect that the technology can be expanded and applied to other areas such as cancer and genetic disorders."



This study, supervised by Professor Mingon Kim of the GIST Department of Chemistry with integrated master's and doctoral student Hyungbin Park as the first author, was supported by the Global Research Network Project and Leading Research Center Support Project (IRC) of the Ministry of Science and ICT and the National Research Foundation of Korea, as well as the Convergence Research Group Project of the National Research Council of Science & Technology (NST). The research findings were published online in the prestigious international journal "Nucleic Acids Research" in the field of biochemistry and molecular biology on March 3, 2026.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing